CRNT vs NDAQ: Which Is the Better Buy in 2026?
Last updated November 2026
Short answer
NDAQ is the larger of the two ($57.95B market cap): the incumbent the market prices for continued execution (21.99x forward earnings, beta 0.96). CRNT is the smaller challenger ($177.08M), cheaper on forward earnings (11.15x): more room to run, but more to prove. If you believe NDAQ earns its premium (21.99x forward earnings, so the market expects more from it), NDAQ fits. If you believe in paying less for profit, CRNT fits at 11.15x.
CRNT vs NDAQ: the tie-breaker metrics
Same yardstick, side by side (as of November 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.
| Metric | CRNT | NDAQ | What it tells you |
|---|---|---|---|
| Market cap | $177.08M | $57.95B | Size. The larger name is the incumbent; the smaller has more room to grow and more to prove. |
| Forward P/E | 11.15 | 21.99 | Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up. |
| Beta | 1.33 | 0.96 | Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through. |
| Price vs 52-week range | 6% of range | 80% of range | Where today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why. |
| Price / book | 1.02 | 4.86 | How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price. |
Reading it: CRNT is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.
Before you buy: how CRNT and NDAQ affect your concentration
The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. CRNT and NDAQ share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.
This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined CRNT and NDAQ exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.
What does Ceragon Networks (CRNT) do?
Ceragon Networks Ltd. (Nasdaq: CRNT), headquartered in Rosh Ha'Ayin, Israel, builds wireless transport equipment. Its core product line is point-to-point microwave and millimeter-wave radio, sold under the IP-50 platform, that mobile operators use to connect cell towers to their core networks without laying fiber. Over the past few years it has broadened that base: it bought Siklu (late 2023) for short-range millimeter-wave links used in cities, campuses and fixed wireless access, and End 2 End Technologies (early 2025) to add private network integration for utilities, mining, energy and public safety customers. It also sells planning, installation and managed services, such as a ~$27M managed services contract with a Colombian mobile operator.
What does Nasdaq (NDAQ) do?
Nasdaq, Inc. is a global markets-infrastructure and financial-technology company. Most people know it for the Nasdaq Stock Market, home to many large technology listings, but the exchange is now only one part of the company. Nasdaq reports across three divisions: Market Services (the trading and exchange business, tied to volumes), Capital Access Platforms (company listings, the fast-growing index and index-linked product business, and investor-relations and ESG analytics), and Financial Technology (software for anti-money-laundering and fraud detection, regulatory technology, and capital-markets trading and risk systems).
CRNT vs NDAQ: how do they differ?
Both fit overlapping themes, but they are not interchangeable. Here is what each one depends on.
- CRNT drivers: India mobile operator buildouts; North American carrier and FR2 opportunity.
- NDAQ drivers: Financial Technology and recurring revenue; Index business and Capital Access Platforms.
Which fits which kind of investor
A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. A useful test is which set of risks you could hold through a drawdown: Customer concentration is the biggest risk. For NDAQ, nasdaq's Market Services division still depends on trading volumes and volatility, so quieter markets can pressure that revenue line.
CRNT or NDAQ: which should you pick?
If the story you believe is CRNT's (India mobile operator buildouts), CRNT is the more direct way to own it; if it is NDAQ's (Financial Technology and recurring revenue), NDAQ is. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the CRNT and NDAQ guides.
CRNT vs NDAQ: the full fundamentals
CRNT. As of November 2026, Ceragon trades at roughly 0.5x trailing revenue and about 1x book value, with EV to EBITDA near 6.5. That is a low multiple even for hardware, and it reflects thin profitability: trailing net income is slightly negative, and guidance implies a non-GAAP operating margin of only 5% to 6% for 2026. The third-quarter margin recovery helps, but the valuation still depends less on revenue growth than on whether margins hold. Six analysts carry a strong-buy consensus with a mean target near $4.92.
NDAQ. Nasdaq is increasingly valued like a data-and-software company rather than a pure exchange, which supports a multiple near 22 times forward earnings but also raises the bar for growth. Q3 2026 EPS of $1.04 edged past the ~$1.02 consensus, the fifth straight beat, and analysts expect about $1.07 per share on ~$1.54 billion of revenue for the December quarter, with results expected around late January 2027. The shares are up ~8% for 2026 and ~20% over a year, and the 16 analysts covering it average a buy rating with a mean target near $115 (BofA raised its target to $135 in November).
Headline figures (approximate, November 2026): CRNT shows revenue (ttm) ~$357M; Q3 2026 ~$95.5M, up ~11.7% YoY, q3 2026 results GAAP net income ~$2.4M; non-GAAP EPS ~$0.07 vs ~$0.04 consensus, gross margin (q3 2026) ~36.0% GAAP, ~36.4% non-GAAP, net income (ttm) ~-$0.9M, roughly break-even; NDAQ shows revenue (ttm) ~$5.8 billion, revenue growth ~12.6% year over year in Q3 2026 (~$1.48 billion), margins Operating ~49%; net ~36%, net income (ttm) ~$2.08 billion (EPS ~$3.66).
The bottom line: CRNT vs NDAQ
CRNT and NDAQ are related but distinct: same themes, different businesses and risks. Neither wins in the abstract, and whichever you pick is worth sizing so one theme does not take over your portfolio. Walnut can show your combined CRNT and NDAQ exposure against your real portfolio. It is not an investment adviser.
Wondering how CRNT or NDAQ fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.
Your questions about Ceragon Networks
Ask Walnut's AI anything about CRNT and see how it fits what you own.
FAQ
What is the difference between CRNT and NDAQ?
+
Ceragon Networks Ltd. Nasdaq, Inc. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.
Is CRNT or NDAQ the better stock?
+
Neither is universally better. NDAQ is the larger incumbent; CRNT is the smaller challenger and looks cheaper on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.
Which is cheaper, CRNT or NDAQ?
+
On forward P/E (as of November 2026), CRNT trades at 11.15x and NDAQ at 21.99x, so CRNT is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.
Should you own both CRNT and NDAQ?
+
Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.
What are the risks of CRNT vs NDAQ?
+
CRNT: Customer concentration is the biggest risk. A few Indian and North American operators account for a large share of revenue, so one carrier delaying or cancelling a rollout can move a quarter by tens of millions of dollars, as the late-2025 North American deferral showed. Margins are the second risk: GAAP gross margin fell to ~31.7% in the second quarter of 2026 and guidance was cut; it recovered to ~36.0% in the third quarter, but a trailing operating margin of about 3.5% leaves little cushion before the company slips into losses. Ceragon competes with much larger vendors such as Ericsson, Nokia, Huawei and ZTE, which can bundle backhaul with radio access equipment and price aggressively. Telecom capital spending is cyclical, and Indian price competition is intense. As an Israeli company with manufacturing and suppliers spread across Asia, Ceragon is exposed to component shortages, currency moves (the Indian rupee and Israeli shekel in particular), tariffs and regional geopolitical risk. The balance sheet is modest, with ~$39.1M of cash at the end of September 2026, so prolonged weakness would limit flexibility. Finally, a share price under $2 and a ~$177M market cap can mean higher volatility and thinner trading than larger telecom stocks. NDAQ: Nasdaq's Market Services division still depends on trading volumes and volatility, so quieter markets can pressure that revenue line. The stock also tends to trade at a premium multiple relative to some exchange peers (about 28.6 times trailing earnings and 10 times sales in November 2026), which leaves less room for error if growth slows. Integration and execution risk around large software acquisitions like Adenza is real: cross-sell targets and synergy assumptions may not fully materialize, and the balance sheet still carries acquisition-related debt. Competition is intense across every division, from ICE, CME, and Cboe in trading to S&P and others in indexes and data, and specialized software vendors in fintech. New competitive threats also emerge, such as analyst concern in 2026 about crypto-derivatives venues and event-contract platforms potentially chipping at parts of the exchange business, and October 2026 commentary questioned whether index-business growth can hold up without a rising market. Listing competition is also widening, with the NYSE and the new Texas Stock Exchange courting the same issuers in November 2026. Regulation of market structure, listings, and financial software is another persistent variable outside the company's control.
Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell CRNT or NDAQ; figures are approximate and dated (as of November 2026). Verify current data before investing.